400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / MAPK/ERK Pathway / RSK / CMK
CAS No.: 821794-90-5
CMK is a RSK2 kinase inhibitor, used for cancer treatment.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03710655 | Multiple Sclerosis | Phase 3 | Not yet recruiting | November 2019 | - |
NCT03635294 | Rare Intellectual Disabilities | Not Applicable | Not yet recruiting | December 2018 | - |
NCT03510598 | Body Fat Disorder | Phase 4 | Active, not recruiting | June 2019 | United States, California ... more >> Rebecca Fitzgerald, MD Dermatology Los Angeles, California, United States, 90004 Collapse << |
实验方案
技术信息
CAS号 | 821794-90-5 | 储存条件 |
|
|
分子式 | C18H19ClN4O2 | 运输 | 蓝冰 | |
分子量 | 358.82 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03710655 | Multiple Sclerosis | Phase 3 | Not yet recruiting | November 2019 | - |
NCT03635294 | Rare Intellectual Disabilities | Not Applicable | Not yet recruiting | December 2018 | - |
NCT03510598 | Body Fat Disorder | Phase 4 | Active, not recruiting | June 2019 | United States, California ... more >> Rebecca Fitzgerald, MD Dermatology Los Angeles, California, United States, 90004 Collapse << |
NCT03637881 | - | - | Active, not recruiting | October 24, 2019 | United States, Illinois ... more >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Collapse << |
NCT02341300 | Iron-deficiency Anemia | Not Applicable | Recruiting | November 2020 | United States, New York ... more >> New York Prebyterian Hospital Weill Cornell Recruiting New York, New York, United States, 10021 Contact: Shari Gelber, MD 212-746-3182 shg7001@med.cornell.edu Contact: Chelsea Clinton, MD 734-223-6103 cmk9008@nyp.org Sub-Investigator: Chelsea Clinton, MD Principal Investigator: Shari Gelber, MD Sub-Investigator: Melissa Yoffee, RD Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网